Use of hepatitis C–positive donors for kidney transplantation

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Transplantation Reviews

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TRRE.2007.07.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Transplantation in the patient with hepatitis C

  2009cited by this paper
• Trasplante renal de donantes virus c positivos: estudio prospectivo de eficacia y seguridad a largo plazo

  2007cited by this paper
• Molecular diagnostics of hepatitis C virus infection: a systematic review.

  2007cited by this paper
• Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss

  2006cited by this paper
• Meta‐analysis: anti‐viral therapy of hepatitis C virus‐related liver disease in renal transplant patients

  2006cited by this paper
• Emerging Issues in Hepatitis C Virus‐Positive Liver and Kidney Transplant Recipients

  2006cited by this paper
• Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.

  2006cited by this paper
• Kidney transplantation from donors with viral B and C hepatitis.

  2006cited by this paper
• Response to ‘Viral Hepatitis Guidelines for Transplant Recipients’

  2005cited by this paper
• Post‐Transplant Diabetes Mellitus and HCV Seropositive Status After Renal Transplantation: Meta‐Analysis of Clinical Studies

  2005cited by this paper
• Interferon Therapy in Hemodialysis Patients with Chronic Hepatitis C: Study of Tolerance, Efficacy and Post-Transplantation Course

  2005cited by this paper
• Hepatitis C Virus Antibody Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies

  2005cited by this paper
• Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: a safe way to expand the donor pool?

  2005cited by this paper
• Natural History of Hepatitis B and C in Renal Allograft Recipients

  2005cited by this paper
• Expanded Criteria Donors: Process and Outcomes

  2005cited by this paper
• Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS/UNOS database.

  2004cited by this paper
• Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant

  2004cited by this paper
• The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.

  2004cited by this paper
• The Impact of Transplantation with Deceased Donor Hepatitis C‐Positive Kidneys on Survival in Wait‐Listed Long‐term Dialysis Patients

  2004cited by this paper
• Hepatitis C, acute humoral rejection, and renal allograft survival.

  2004cited by this paper
• The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure.

  2004cited by this paper
• Severe Hepatitis C Infection in a Renal Transplant Recipient Following Hepatitis C Genotype Mismatch Transplant

  2004cited by this paper
• Guía sobre Enfermedades Víricas en Hemodiálisis

  2004cited by this paper
• Use of kidneys from hepatitis C seropositive donors shortens waitlist time but does not alter one‐yr outcome *

  2003cited by this paper
• Hepatitis C and renal transplantation in the era of modern immunosuppression.

  2003cited by this paper
• Cost analysis of renal replacement therapies in Finland.

  2003cited by this paper
• Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

  2003cited by this paper
• A trial of objective comparison of quality of life between chronic renal failure patients treated with hemodialysis and renal transplantation.

  2003cited by this paper
• Kidney and pancreas transplantation

  2003cited by this paper
• Pretransplant Interferon Prevents Hepatitis C Virus‐Associated Glomerulonephritis in Renal Allografts by HCV‐RNA Clearance

  2003cited by this paper
• Hepatitis C virus-positive patients on the waiting list for transplantation.

  2002cited by this paper
• Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.

  2002cited by this paper
• Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation.

  2002cited by this paper
• Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation

  2002cited by this paper
• Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus)

  2002cited by this paper
• Hepatitis C antibody status and outcomes in renal transplant recipients.

  2001cited by this paper
• Solute fluxes in different treatment modalities.

  2000cited by this paper
• Policies concerning the use of kidneys from donors infected with hepatitis C virus.

  2000cited by this paper
• Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors

  2000cited by this paper
• Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients.

  2000cited by this paper
• 10 YEARS' EXPERIENCE IN TRANSPLANTATION OF KIDNEYS FROM HEPATITIS C VIRUS POSITIVE DONORS INTO HEPATITIS C VIRUS POSITIVE RECIPIENTS.: Abstract# 1120

  2000cited by this paper
• Impact of hepatitis B and C virus on kidney transplantation outcome

  1999cited by this paper
• Impaired kidney transplant survival in patients with antibodies to hepatitis C virus.

  1999cited by this paper
• Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

  1999cited by this paper
• Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

  1998cited by this paper
• Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation.

  1998cited by this paper
• Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation.

  1998cited by this paper
• Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease1

  1998cited by this paper
• Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

  1998cited by this paper
• Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

  1998cited by this paper
• The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients.

  1997cited by this paper
• Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients.

  1997cited by this paper
• Hepatitis C virus infection in dialysis and renal transplantation.

  1997cited by this paper
• Should hepatitis C positive donors be accepted for renal transplantation?

  1996cited by this paper
• Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts.

  1996cited by this paper
• Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.

  1995cited by this paper
• Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection.

  1995cited by this paper
• De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.

  1995cited by this paper
• Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney.

  1995cited by this paper
• Hepatitis C virus: the nephrologist's view.

  1995cited by this paper
• The impact of hepatitis C virus infection on renal allograft recipients.

  1994cited by this paper
• Transmission of hepatitis C by kidney transplantation--the risks.

  1994cited by this paper
• Infectious disease complications of renal transplantation.

  1993cited by this paper
• Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients.

  1993cited by this paper
• Hepatitis C virus and organ transplantation.

  1993cited by this paper
• Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.

  1993cited by this paper
• Lack of protective immunity against reinfection with hepatitis C virus

  1992cited by this paper
• Transmission of HCV by organ transplantation.

  1992cited by this paper
• Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.

  1992cited by this paper
• Hepatitis C virus in kidney recipients

  1992cited by this paper
• Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.

  1992cited by this paper
• Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease

  1992cited by this paper
• Hepatitis C virus infection among kidney transplant recipients.

  1991cited by this paper
• Transmission of hepatitis C virus by organ transplantation.

  1991cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• THE BLOOD VESSELS IN THE CENTRAL NERVOUS SYSTEM OF THE KANGAROO.

  1938cited by this paper

• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cites this paper
• Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection

  2011cites this paper
• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cites this paper
• Transplantation in the patient with hepatitis C

  2009cites this paper